📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
45
Warrant Exposure
70
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split
65%
• 50-day avg $0.11 below $1 exchange minimum
• 12 months cash with weak price
📜 Warrant Exercise
40%
• Significant warrants: 21% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise
15%
• Under 12 months cash (12mo)
💹 Market Data
Market Cap$434.6K
Shares Outstanding1.74M
Float1.22M
Cash$22.45M
Debt$2.38M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest10.6K
Days to Cover16.9
% of Float0.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2023
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CRKN
📊 CRKN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CRKN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.